跳至主要内容
临床试验/jRCTs052240042
jRCTs052240042招募中不适用

Phase II study to evaluate the safety and efficacy of esophageal stenting for benign esophageal perforation and fistula

未提供0 个研究点目标入组 15 人开始时间: 2024年11月6日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
15
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
18age old over 至 No limit(—)
性别
All

入选标准

  • Patients who meet all of the following criteria are included
  • Benign esophageal perforation or fistula is confirmed by endoscopy.
  • Difficult to close with existing therapies.
  • No obvious abscess in the mediastinum or abdominal cavity.
  • The patient is at least 18 years of age at the time consent is obtained.
  • Written consent to participate in the study has been obtained from the patient.

排除标准

  • Patients with any one of the following conditions are excluded
  • Systolic blood pressure less than 90 mmHg.
  • Pregnant women or patients who may be pregnant.
  • Other patients deemed inappropriate by the principal investigator or sub-investigator.

结局指标

主要结局

-

Clinical success rate

次要结局

未报告次要终点

研究者

发起方
未提供

相似试验